Microfluidics-derived hierarchical microparticles for the delivery of dienogest for localized endometriosis therapy
Microfluidics-fabricated hierarchical microparticles encapsulate dienogest-loaded microspheres to achieve sustained release and cell adhesion for localized endometriosis treatment, demonstrating anti-inflammatory and anti-angiogenic effects in vivo.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (55)
- A mouse model of endometriosis that displays vaginal, colon, cutaneous, and bladder sensory comorbidities via openalex
- Antiangiogenesis Therapy for Endometriosis via openalex
- Comparison of efficacy of bromocriptine and cabergoline to GnRH agonist in a rat endometriosis model via openalex
- Endometriosis via openalex
- Endometriosis: A Disease with Few Direct Treatment Options via openalex
- Long-Term Administration of Dienogest for the Treatment of Pain and Intestinal Symptoms in Patients with Rectosigmoid Endometriosis via openalex
- Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells via openalex
- Nonsurgical mouse model of endometriosis-associated pain that responds to clinically active drugs via openalex
- Novel Medicine for Endometriosis and Its Therapeutic Effect in a Mouse Model via openalex
- The Potential Effect of Fucoidan on Inhibiting Epithelial-to-Mesenchymal Transition, Proliferation, and Increase in Apoptosis for Endometriosis Treatment: In Vivo and In Vitro Study via openalex
- The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval via openalex
- Update on endometriosis pathogenesis via openalex
- Use of dienogest in endometriosis: a narrative literature review and expert commentary via openalex
- W2921649378 via openalex
- W2970083543 via openalex
- W2996266725 via openalex
- W2999841188 via openalex
- W3016334905 via openalex
- W3043172017 via openalex
- W3048131598 via openalex
- W3134885188 via openalex
- W3153128705 via openalex
- W3175662601 via openalex
- W3180804871 via openalex
- W3196168773 via openalex
- W3197003023 via openalex
- W4200355601 via openalex
- W4206619128 via openalex
- W4210481130 via openalex
- W4211127517 via openalex
- W4229377134 via openalex
- W4234160457 via openalex
- W4283390809 via openalex
- W4286697968 via openalex
- W4306918464 via openalex
- W4311573126 via openalex
- W4321602234 via openalex
- W4327714853 via openalex
- W4366240179 via openalex
- W4385851713 via openalex
- W6736467252 via openalex
- W6805488865 via openalex
- W6806908988 via openalex
- W1965699572 via openalex
- W1998380582 via openalex
- W2040932988 via openalex
- W2293579526 via openalex
- W2326952233 via openalex
- W2548144690 via openalex
- W2617378503 via openalex
- W2740636098 via openalex
- W2808449407 via openalex
- W2809514115 via openalex
- W2908838385 via openalex
- W2908903548 via openalex
Cited by (5)
- NRF2 Signalling in Endometriosis: A Hormone-Independent Axis for Fertility-Preserving Therapeutic Innovation 2026
- Nanomaterial Platforms for Endometriosis: A Systematic Review 2026
- What are the most significant challenges in understanding and managing endometriosis today? 2025
- Enhanced peroperative imaging of endometriosis and peritoneal carcinomatosis 2024
- Emerging strategies for the treatment of endometriosis 2024
Source provenance
- europepmc
- last seen: 2026-09-16T06:11:32.772430+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-09-16T06:09:33.136173+00:00